Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for …
AK Stewart, R Vescio, G Schiller, O Ballester… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: Although high-dose chemotherapy supported by autologous peripheral-blood
progenitor-cell (PBPC) transplantation improves response rates and survival for patients …
progenitor-cell (PBPC) transplantation improves response rates and survival for patients …
Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC)
W Vogel, S Scheding, L Kanz, W Brugger - Stem Cells, 2000 - academic.oup.com
Recently, a number of devices have been developed for the positive selection of CD34+
peripheral blood progenitor cells (PBPC) for clinical use in autologous or allogeneic …
peripheral blood progenitor cells (PBPC) for clinical use in autologous or allogeneic …
A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative …
S Kasimir-Bauer, C Oberhoff… - International …, 2002 - spandidos-publications.com
Although only less than 10% of women with primary breast cancer have clinicopathologic
signs of overt metastases, metastatic relapse occurs in about half of the cases with …
signs of overt metastases, metastatic relapse occurs in about half of the cases with …
Capture and enrichment of CD34‐positive haematopoietic stem and progenitor cells from blood circulation using P‐selectin in an implantable device
JC Wojciechowski, SD Narasipura… - British journal of …, 2008 - Wiley Online Library
Clinical infusion of haematopoietic stem and progenitor cells (HSPCs) is vital for restoration
of haematopoietic function in many cancer patients. Previously, we have demonstrated an …
of haematopoietic function in many cancer patients. Previously, we have demonstrated an …
Eradication of Multiple Myeloma and Breast Cancer Cells by TH9402‐mediated Photodynamic Therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem …
N Brasseur, I Menard, A Forget… - Photochemistry and …, 2000 - Wiley Online Library
High‐dose chemotherapy combined with autologous transplantation using bone marrow or
peripheral blood‐derived stem cells (PBSC) is now widely used in the treatment of …
peripheral blood‐derived stem cells (PBSC) is now widely used in the treatment of …
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose …
S Kasimir-Bauer, S Mayer, P Bojko, D Borquez… - Clinical cancer …, 2001 - AACR
Purpose: We evaluated whether dose-intensive or high-dose chemotherapy can eliminate
micrometastases in high-risk breast cancer patients. Experimental Design: We monitored …
micrometastases in high-risk breast cancer patients. Experimental Design: We monitored …
Impact of fetal umbilical cord blood CD34+ cells on breast cancer cell lines: a mechanism of fetal microchimerism?
K Kolanska, M Roche, C Carrière, M Le Gac… - Cells Tissues …, 2024 - karger.com
Introduction: Fetal microchimerism could be involved in the regulation of breast cancer
oncogenesis. CD34+ cells could be of a particular interest as up to 12% of the CD34+ …
oncogenesis. CD34+ cells could be of a particular interest as up to 12% of the CD34+ …
Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's …
M Mohr, F Dalmis, E Hilgenfeld, E Oelmann… - Clinical cancer …, 2001 - AACR
The reduction of residual tumor cells is one of the main targets of leukapheresis product (LP)
processing. Immunomagnetic enrichment/selection of CD34+ progenitor cells (Baxter Isolex …
processing. Immunomagnetic enrichment/selection of CD34+ progenitor cells (Baxter Isolex …
[HTML][HTML] Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and …
Y Nieto, WA Franklin, RB Jones, SI Berman… - Biology of Blood and …, 2004 - Elsevier
We prospectively evaluated the prognostic significance of occult tumor cells (OTCs)
contaminating the peripheral blood progenitor cell apheresis products of patients with …
contaminating the peripheral blood progenitor cell apheresis products of patients with …
Flow Cytometric CD34+ Determination in Stem Cell Transplantation: Before or after Cryopreservation of Grafts?
T Fietz, B Reufi, C Mücke, E Thiel… - … of Hematotherapy & …, 2002 - liebertpub.com
Various attempts have been made to standardize and improve the reproducibility of flow
cytometric determination of CD34+ hematopoietic progenitor cells. It is still not clear …
cytometric determination of CD34+ hematopoietic progenitor cells. It is still not clear …